Cardiac resynchronization therapy with and without implantable cardioverter-defibrillator

Circulation Journal

Volumn 73, Issue SUPPL. A, 2009, Pages

  Shimizu, Akihiko ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CRT; CRT D; Heart failure

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; DISEASE SEVERITY; ECG ABNORMALITY; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; JAPAN; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; QRS COMPLEX; REVIEW; SINUS RHYTHM; TREATMENT INDICATION;

CARDIAC RESYNCHRONIZATION THERAPY; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; PATIENT SELECTION; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67650603307     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1085     Document Type: Review

References (76)

1. Bakker PF, Meijburg H, de Jonge N. Beneficial effects of biventricular pacing in congestive heart failure (abstract). Pacing Clin Electrophysiol 1994; 17: 820.
2. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, et al. Multisite pacing for end-stage heart failure: Early experience. Pacing Clin Electrophysiol 1996; 19: 1748-1757.
3. Gregoratos G, Abrams J, Epstein AE, Freesman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145-2161.
4. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for diagnosis and treatment of CHF: Executive summary (up data 2005): Task Force for Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140.
5. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francic GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
6. Zipes DP, Camm J, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: 247-346.
7. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. The Task Force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology: Developed in collaboration with the European Heart Rhythm Association: Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2007; 28: 2256-2295.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, et al. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
9. 1999-2000 Consensus Reports. Guidelines for non-pharmacological therapy of cardiac arrhythmia. Guide line in the diagnosis and therapy for cardiovascular disease. Jpn Circ J 2001; 65(Suppl V): 1127-1160.
10. Tanno K, Kobayashi Y. Prophylactic ICD implantation in patients with low cardiac function-Japanese current guidelines and clinical significant of prophylactic ICD Implantation (in Japanese). SHINZO 2007; 39: 596-600.
11. Gottipaty VK. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure. J Am Coll Cardiol 1999; 33(Suppl): 145A.
12. Hawkins NM, Petrie MC, Mac Donald MR, Hogg KJ, McMurray JJV. Selecting patients for cardiac resynchronization therapy; electrical or mechanical dyssynchrony? Eur Heart J 2006; 27: 1270-1281.
13. Spragg DD, Leclercq C, Loghmani, Faris OP, Tunin RS, DiSilvestre D, et al. Regional alternations in protein expression in the dyssynchronous failing heart. Circulation 2003; 108: 929-932.
14. Nowak B, Sinha A, Schaefer W, Koch KC, Kaiser HJ, Hanrath P, et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003; 41: 1523-1528.
15. Ukkonenen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, et al. Effect of cardiac resynchronization on myocardial efficacy and regional oxidative metabolism. Circulation 2003; 107: 28-31.
16. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002; 105: 438-445.
17. Cazeau S, Bordachar P, Jauvert G, Lazarus A, Alonso C, Vandrell MC, et al. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: A prospective study. Pacing Clin Electrophysiol 2003; 26(Part II): 137-143.
18. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102: 3053-3059.
19. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, et al. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000; 102: 1027-1032.
20. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay (MUSTIC SR). N Engl J Med 2001; 344: 873-880.
21. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. For the MIRACLE Study Group: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
22. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. For the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685-2694.
23. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454-1459.
24. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, et al. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic heart failure. Circulation 2004; 110: 2864-2868.
25. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, et al. Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
26. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
27. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Long-term effects of cardiac resynchronization therapy on mortality in heart failure [The Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006; 27: 1928-1932.
28. Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Rationale and design of a randomized controlled trail to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure-the Resynchronization reVEeres Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006; 151: 288-294.
29. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptom. J Am Coll Cardiol 2008; 52: 1834-1843.
30. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, Van Der Wall EE, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005; 112: 1580-1586.
31. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. JAMA 2007; 297: 2502-2514.
32. Rivero-Ayerza M, Theunus DA, Gracia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials. Eur Heart J 2006; 27: 2682-2688.
33. Gasparini M, Mantica M, Galimberti P, Genovese L, Pini D, Faletra F, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003; 26(1 Pt2): 175-180.
34. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93: 860-863.
35. Diaz-infante E, Mont L, Leal J, Garcia-Bolao I, Fernandez-Lozano I, Hernandez-Madrid A, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005; 95: 1436-1440.
36. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006; 113: 266-272.
37. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006; 113: 969-976.
38. Stevenson WG, Stevenson LW. Atrial fibrillation in heart failure. N Engl J Med 1999; 341: 910-911.
39. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathology and rationale for therapy. Am J Cardiol 2003; 91(6A): 15D-26D.
40. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovascu Electrophysiol 2005; 16: 1160-1165.
41. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from Multisite Stimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002; 40: 111-118.
42. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, et al. Four-year efficacy of cardiac resynchronization therapy on excersise tolerance and disease progression: The importance of performing atrioventricular junctional ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006; 48: 734-743.
43. Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2005; 46: 2208-2214.
44. Tada H, Toide H, Okaniwa H, Higuchi R, Nakajima T, Utsugi R, et al. Maximum ventricular dyssynchrony predicts the clinical improvement and reserve remodeling in patients receiving biventricular pacing. Pacing Clini Electrophsiol 2007; 30(S1): S13-S18.
45. Yu CM, Abraham WT, Bax J, Chung E, Fedewa M, Ghio S, et al. PROSPECT Investigators: Predictors of response to cardiac resynchronization therapy (PROSPECT)-study design. Am Heart J 2005; 149: 600-605.
46. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616.
47. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, et al. Predicting the Long-Term Effects of Cardiac Resynchronization Therapy on Mortality From Baseline Variables and the Early Response: A Report From the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol 2008; 52: 438-445.
48. Cazeau SJ, Daubert JC, Tavazzi L, Frohlig G, Paul V. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complex indentified by simple echocardiographyic indices of dyssynchrony: The DESIRE study. Eur Heart J 2008; 10: 273-280.
49. Leclercq C, Kass DA. Retiming the failing heart: Principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39: 194-201.
50. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006; 48: 2251-2257.
51. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006; 48: 2243-2250.
52. Beshai JF, Grimm RA, Nagueh SF, Baker JH, Beau SL, Greenberg SM, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007; 357: 2461-2471.
53. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 2007; 115: 204-212.
54. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
55. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. The multicenter autonomic defibrillator implantation trial II investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
56. Bardy GH, Lee KL, Mark DB, Polle J, Pacher D, Boineau R, et al. The sudden cardiac death in heart failure trial (SCD-HeFT) investigators: Amioradone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
57. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003; 138: 445-452.
58. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 292: 2874-2879.
59. Kadish A, Dyer A, Daubert JP, Quigg R, Esters MAM, Anderson KP, et al. Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators: Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
60. De Lurgio DB, Foster E, Higginbotham MB, Larntz K, Saxon LA. A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: Rationale and design of the DECREASE-HF clinical trial. J Card Fail 2005; 11: 233-239.
61. Saxon LA. Defining response and defining how we measure response to CRT. J Cardiovasc Electrophysiol 2007; 18: 1020-1021.
62. Bronke JP, Turkington D, Thoma G, MaComb JM, Tynan M. Florid phychopathology in patients receiving shocks from implanted cardioverter- defibrillators. Heart 1997; 78: 581-583.
63. Hegle MT, Griegel LE, Black C, Goulden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: A longitudinal investigation. Int J Psychiatry Med 1997; 27: 57-69.
64. Luderatz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 1993; 16: 1815-1821.
65. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
66. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999; 34: 402-408.
67. Wilkoff B (DAVID Trial Investigators). Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator; Thedual chamber and VVI implantable defbrilaltor (DAVID) trial. JAMA 2002; 288: 3115-3123.
68. Yao GL, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007; 28: 42-51.
69. Shimizu A, Nitta T, Kurita T, Imai K, Kimura T, Kobayashi Y, et al. Current status of implantable defibrillator devices in patients with left ventricular dysfunction: The first report from the online registry database. J Arrhythmia 2008; 24: 133-140.
70. Shimamoto T, Marui A, Takagi T, Komeda M. Significance of morphological and electrophysiological left ventricular restoration in idiopathic dilated cardiomyopathy. Interact Cardiovasc Thorac Surg 2008; 7: 931-932.
71. Nishimura M, Ogiwara M, Ishikawa M, Imanaka K, Okamura N, Kato M, et al. Successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy. J Artif Organs 2005; 8: 210-213.
72. Greenberg SM, Epstein AE, Deering T, Goldman DS, Chidina M, Neason C, et al. A comparison of ICD Implantations in the United States versus Italy. Pacing Clin Electrophysiol 2007; 30: S143-S146.
73. Komura S, Chinushi M, Kudo M, Saikawa T, Tanabe Y, Furushima H, et al. Potential candidates for cardiac resynchronization therapy in Japanese patients with idiopathic dilated cardiomyopathy: A Niigata multicenter study of DCM. Circ J 2004; 68: 1104-1109.
74. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005; 69: 19-22.
75. Kurita T. Primary prevention of sudden cardiac death in patients with ischemic heart disease -possible role of the shock device in the Asia. J Arrhythmia 2007; 23: 264-268.
76. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471-1480.